GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021

ESMO-IO will publish full abstracts on their website on Thursday, December 2 at 12:00 pm CET . GT Biopharma will post its poster on the company's website in the "Presentations"  section during the conference.

Related Keywords

Switzerland ,Beverly Hills ,Exchange Commission ,University Of Minnesota ,Gt Biopharma Inc ,European Society For Medical Oncology ,Oncology Io Congress ,European Society ,Medical Oncology ,Poster Display Title ,Tri Specific Killer Engager ,Annual Report ,Quarterly Report ,Securities Act ,Cancer ,Congress ,Forward Looking Statement ,Genetic Engineering ,Immune System ,Immunology ,Medical Specialties ,Therapeutics ,Antibody ,Branches Of Biology ,Cancer Immunotherapy ,Natural Killer Cell ,Single Domain Antibody ,